Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
35%
OVERLAP
BY WEIGHT
11
# OF OVERLAPPING
HOLDINGS
MEDX
27
HOLDINGS
41%
ALSO IN HRTS
HRTS
42
HOLDINGS
26%
ALSO IN MEDX
SECTOR DRIFT (MEDX minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in MEDX |
Weight in HRTS |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 16.0% | 10.0% | 10.0% |
 |
ASTRAZENECA PLC | 6.0% | 5.1% | 5.1% |
|
JOHNSON & JOHNSON | 5.8% | 4.7% | 4.7% |
|
MERCK & CO. INC. | 4.1% | 4.4% | 4.1% |
|
ABBVIE INC | 8.1% | 2.8% | 2.8% |
MEDX Overweight Relative to HRTS
 |
NOVARTIS AG-ADR | 7.5% |
|
ELI LILLY & CO | 6.0% |
|
ABBVIE INC | 5.2% |
|
IONIS PHARMACEUTICALS, INC. | 3.9% |
 |
ALKERMES PLC | 3.9% |
|
PFIZER INC | 3.5% |
|
GLAXOSMITHKLINE PLC-SPON ADR | 3.3% |
|
ALNYLAM PHARMACEUTICALS INC | 2.8% |
|
BRISTOL-MYERS SQUIBB CO | 2.8% |
|
CRISPR THERAPEUTICS AG | 2.7% |
MEDX Underweight Relative to HRTS
|
ROCHE HOLDINGS LTD-SPONS ADR | -4.9% |
|
UNITEDHEALTH GROUP INC | -4.3% |
|
THERMO FISHER SCIENTIFIC INC | -4.1% |
|
GILEAD SCIENCES INC | -3.6% |
|
NOVARTIS AG | -3.5% |
|
VERTEX PHARMACEUTICALS INC | -3.2% |
|
ABBOTT LABORATORIES | -3.1% |
|
BRIDGEBIO PHARMA, INC. | -3.0% |
|
DANAHER CORP | -2.8% |
 |
NOVO NORDISK A/S-B | -2.3% |